Author:
Armstrong Terri S.,Cao Yumei,Scheurer Michael E.,Vera-Bolaños Elizabeth,Manning Rochelle,Okcu Mehmet F.,Bondy Melissa,Zhou Renke,Gilbert Mark R.
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Clinical Neurology,Oncology
Reference24 articles.
1. Stupp R, Hegi ME, van den Bent MJ, et al. Changing paradigms— an update on the multidisciplinary management of malignant glioma. Oncologist. 2006;11(2):165-180.
2. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996.
3. Schering-Plough. Temozolomide prescribing information. Version 3/14/05. Schering-Plough Research Institute, Kenilworth, NJ. 2005. Available at http://www.spfiles.com/pitemodar.pdf. Accessed February 21, 2009.
4. Doyle TJ, Middelsen T, Croteau D. Fatal hematologic toxicity with prolonged continuous administration of temozolomide (TMZ) during radiation therapy (RT) in the treatment of newly-diagnosed glioblastoma multiforme (GBM): Report of a phase II trial [abstract]. J Clin Oncol. 23(16 suppl):1546.
5. Gerber DE, Grossman SA, Zeltzman M, Parisi MA, Kleinberg L. The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas. Neuro-Oncology. 2007;9(1):47-52.
Cited by
70 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献